Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Technology

• Publication date

  2016-05-18

• Fields of study

  Biology, Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1142/S2339547816400100PMID 27774502PMCID PMC5072529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scavenger Receptor SREC-I Mediated Entry of TLR4 into Lipid Microdomains and Triggered Inflammatory Cytokine Release in RAW 264.7 Cells upon LPS Activation

  2015cited by this paper
• In vivo toxicity of cationic micelles and liposomes.

  2015cited by this paper
• Non-viral vectors for gene-based therapy

  2014cited by this paper
• Enhancing endosomal escape for nanoparticle mediated siRNA delivery.

  2014cited by this paper
• Polymer-enhanced delivery increases adenoviral gene expression in an orthotopic model of bladder cancer.

  2014cited by this paper
• Delivery materials for siRNA therapeutics.

  2013cited by this paper
• Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling

  2013cited by this paper
• Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNA.

  2013cited by this paper
• Nanoparticle geometry and surface orientation influence mode of cellular uptake.

  2013cited by this paper
• Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape.

  2013cited by this paper
• The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing

  2013cited by this paper
• Scavenger receptors in homeostasis and immunity

  2013cited by this paper
• Design of siRNA Therapeutics from the Molecular Scale

  2013cited by this paper
• Gene silencing by chemically modified siRNAs.

  2013cited by this paper
• ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS.

  2012cited by this paper
• Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake.

  2012cited by this paper
• In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery.

  2012cited by this paper
• Biologics inch toward cholesterol-lowering market

  2012cited by this paper
• Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective.

  2012cited by this paper
• Biocompatibility of mesoporous silica nanoparticles.

  2012cited by this paper
• Nucleic acid delivery: the missing pieces of the puzzle?

  2012cited by this paper
• Safety profile of RNAi nanomedicines.

  2012cited by this paper
• RNA-based therapeutics: current progress and future prospects.

  2012cited by this paper
• siRNA repositioning for guide strand selection by human Dicer complexes.

  2011cited by this paper
• Magnetic nanoparticles as targeted delivery systems in oncology

  2011cited by this paper
• Endosomal escape pathways for delivery of biologicals.

  2011cited by this paper
• Biomedical Applications of Biodegradable Polymers.

  2011cited by this paper
• Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies.

  2011cited by this paper
• Silencing or stimulation? siRNA delivery and the immune system.

  2011cited by this paper
• Current progress of siRNA/shRNA therapeutics in clinical trials

  2011cited by this paper
• Elimination pathways of systemically delivered siRNA.

  2011cited by this paper
• Mesoporous silica nanoparticles for intracellular controlled drug delivery.

  2010cited by this paper
• Recognition of siRNA asymmetry by TAR RNA binding protein.

  2010cited by this paper
• Lipid‐based nanotherapeutics for siRNA delivery

  2010cited by this paper
• Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease

  2010cited by this paper
• A role for human Dicer in pre-RISC loading of siRNAs

  2010cited by this paper
• Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.

  2010cited by this paper
• Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity.

  2010cited by this paper
• A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery

  2009cited by this paper
• Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins

  2009cited by this paper
• The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

  2009cited by this paper
• Recent developments in carbohydrate‐decorated targeted drug/gene delivery

  2009cited by this paper
• Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis.

  2008cited by this paper
• In vitro reconstitution of the human RISC-loading complex

  2008cited by this paper
• Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo.

  2008cited by this paper
• A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

  2008cited by this paper
• MicroRNA silencing through RISC recruitment of eIF6

  2007cited by this paper
• Progress Toward In Vivo Use of siRNAs-II

  2006cited by this paper
• Double-stranded RNA Is Internalized by Scavenger Receptor-mediated Endocytosis in Drosophila S2 Cells*

  2006cited by this paper
• Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes.

  2005cited by this paper
• In vivo activity of nuclease-resistant siRNAs.

  2004cited by this paper
• A Protein Sensor for siRNA Asymmetry

  2004cited by this paper
• Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

  2004cited by this paper
• Molecular mechanism of Peptide-induced pores in membranes.

  2004cited by this paper
• Phagosome maturation: aging gracefully.

  2002cited by this paper
• Surface modification of poly(lactic acid) nanospheres using hydrophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique.

  2000cited by this paper
• Interactions of functionalized dextran-coated liposomes with vascular smooth muscle cells.

  2000cited by this paper
• Modified LDLs are internalized by macrophages in part via macropinocytosis

  1999cited by this paper
• Liposomes coated with chemically modified dextran interact with human endothelial cells.

  1999cited by this paper
• Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent

  1999cited by this paper
• Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system.

  1998cited by this paper
• Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.

  1997cited by this paper
• Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro.

  1996cited by this paper
• Cell killing by lysosomotropic detergents

  1983cited by this paper

• Activation of Immune Responses Through the RIG-I Pathway Using TRITC-Dextran Encapsulated Nanoparticles

  2024cites this paper
• Natural Polymers in Pharmaceutical Nanotechnology

  2021cites this paper
• Boosting transfection efficiency: A systematic study using layer-by-layer based gene delivery platform.

  2021cites this paper
• Recent advances in polysaccharides based biomaterials for drug delivery and tissue engineering applications

  2021cites this paper
• Delivery of Ultrasmall Nanoparticles to the Cytosolic Compartment of Pyroptotic J774A.1 Macrophages via GSDMDNterm Membrane Pores.

  2021cites this paper
• Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy

  2021cites this paper
• Kinetic analysis of the intracellular processing of sirnas by confocal microscopy.

  2020cites this paper
• Biomimetic Dextran-Peptide Vectors for Efficient and Safe siRNA Delivery.

  2019cites this paper
• Endocytosis Controls siRNA Efficiency: Implications for siRNA Delivery Vehicle Design and Cell-Specific Targeting

  2019cites this paper
• Preparation and application of dextran and its derivatives as carriers.

  2019cites this paper
• Cytosolic Uptake of Large Monofunctionalized Dextrans.

  2018cites this paper
• Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption

  2018cites this paper